Latest News.
ShanX Medtech at the Hello Tomorrow Global Summit in Paris
Earlier this year we were recognized as Deep Tech Pioneers by Hello Tomorrow. This allows us to attend the Hello Tomorrow Investor Day and Global Summit in Paris on Dec. 1st - 3rd. The Global Summit welcomes prestigious scientists, entrepreneurs and brilliant minds to discuss, debate and share cutting-edge...
ShanX Medtech at the MEDICA fair in Düsseldorf
MEDICA is taking place in Düsseldorf on November 15-18, 2021. The event is a leading international trade fair, and it is a wonderful place to meet partners in exhibition halls. As such we will be attending the event. If you want to meet us and discover what we do...
ShanX Medtech is speaking at the MEDICA Healthcare Brokerage Event 2021
On the occasion of MEDICA 2021 (15 - 18 November 2021), the global No. 1 meeting place for the medical sector, ZENIT GmbH together with the Healthcare Sector Group of the Enterprise Europe Network are organizing the international Brokerage Event. ShanX Medtech is being given the opportunity to introduce...
ShanX Medtech recognized as a Deep Tech Pioneer by Hello Tomorrow
We are delighted to have been named one of Hello Tomorrow’s Deep Tech Pioneers! Being a Deep Tech Pioneer means that we’ve been recognised by Hello Tomorrow as one the most promising technologies in deep tech to date. Over 4000 technologies were submitted from 115 countries, and ours was...
Founder and CEO, Sophia E. Shanko on the TOPX Summit on 22-23 September
Women are still underrepresented in high level positions even nowadays. Though there are more women than men in Europe only 16% of European startups are founded or co-founded by women. The TOPX Network aims to create a unique and valuable network for ambitious women in Life Sciences by supporting their...
ShanX Medtech is awarded the MIT feasibility study
ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy. This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally...
ShanX Medtech and New Circle Technologies are partnering to develop a prototype software algorithm that can determine fast antibiotic efficacy.
ShanX Medtech and New Circle Technologies are partnering to develop a prototype software algorithm that can quickly determine antibiotic efficacy. The DIGI-B-CUBE project has been awarded to accelerate the goal of personalized medicine that can eventually offer patients with fast and efficient treatment system. This project has received funding from...
ShanX Medtech at Innovation for Health 2020 in Rotterdam
ShanX Medtech will attend the Innovation for Health 2020 on February the 12th and 13th 2020 at the De Doelen ICC in Rotterdam!
ShanX Medtech is awarded a grant by the Metropoolregio Eindhoven
Antibiotic resistance is a public global health issue. Unnecessary and injudicious antibiotic use may contribute to the rise of antibiotic resistance. To tackle this use, regulating antibiotic administration is very important. The Metropool Regio Eindhoven is supporting ShanX Medtech in the development of an antibiotic efficiency testing device.
